Evidence map›Paper›PMID 30103695›Full record

ArticleBMC neurology2018

The Swiss Multiple Sclerosis Registry (SMSR): study protocol of a participatory, nationwide registry to promote epidemiological and patient-centered MS research.

Nina Steinemann, Jens Kuhle, Pasquale Calabrese, Jürg Kesselring, Giulio Disanto, Doron Merkler, Caroline Pot, Vladeta Ajdacic-Gross, Stephanie Rodgers, Milo Alan Puhan and 2 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMC neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02980640 (Swiss Multiple Sclerosis Registry), which is not on this map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02980640 recruitingnot on this map

Swiss Multiple Sclerosis Registry

Typeobservational_patient_registrySponsorSwiss Multiple Sclerosis RegistryRan2016 to 2041Enrolled10,000ConditionsMultiple Sclerosis
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 55 citations in OpenAlex.

  1. Trial
  2. Article
  3. Big data in multiple sclerosis.Current opinion in neurology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Nina SteinemannEpidemiology, Biostatistics and Prevention Institute, University of Zurich, Hirschengraben 84, CH-8001, Zurich, Switzerland.
Jens KuhleNeurological Policlinic, University Hospital Basel, Basel, Switzerland.
Pasquale CalabreseDepartment of Psychology, University of Basel, Basel, Switzerland.
Jürg KesselringRehabilitation Clinic Valens, Valens, Switzerland.
Giulio DisantoDepartment of Neurology, Regional Hospital Lugano (EOC), Lugano, Switzerland.
Doron MerklerDivision of Clinical Pathology, Geneva University Hospital, Geneva, Switzerland.
Caroline PotDepartment of Clinical Neuroscience, Centre hospitalier universitaire vaudois, Lausanne, Switzerland.
Vladeta Ajdacic-GrossEpidemiology, Biostatistics and Prevention Institute, University of Zurich, Hirschengraben 84, CH-8001, Zurich, Switzerland.
Stephanie RodgersEpidemiology, Biostatistics and Prevention Institute, University of Zurich, Hirschengraben 84, CH-8001, Zurich, Switzerland.
Milo Alan PuhanEpidemiology, Biostatistics and Prevention Institute, University of Zurich, Hirschengraben 84, CH-8001, Zurich, Switzerland.
Viktor von WylEpidemiology, Biostatistics and Prevention Institute, University of Zurich, Hirschengraben 84, CH-8001, Zurich, Switzerland. viktor.vonwyl@uzh.ch.ORCID http://orcid.org/0000-0002-8754-9797
Swiss Multiple Sclerosis Registry
University of Zurich · CHOspedale regionale di Lugano · CHUniversity of Basel · CHPrevention Institute · USUniversity Hospital of Lausanne · CH

Funding

Swiss Multiple Sclerosis Society n.a.
6 · The paper itself

Abstract

backgroundMultiple sclerosis (MS) is one of the most frequently observed neurological conditions in Switzerland, but data sources for country-wide epidemiological trend monitoring are lacking. Moreover, while clinical and laboratory MS research are generally well established, there is a gap in patient-centered MS research to inform care management, or treatment decisions and policy making not only in Switzerland but worldwide.

methodsIn light of these research gaps, the Swiss Multiple Sclerosis Society initiated and funded the Swiss Multiple Sclerosis Registry (SMSR) an open-ended, longitudinal and prospective, nationwide, patient-centered study. The SMSR recruits adult persons with a suspected or confirmed MS diagnosis who reside or receive care in Switzerland. The SMSR has established a governance structure with clear rules and guidelines. It follows a citizen-science approach with direct involvement of persons with MS (PwMS), who contribute actively to registry development, operations, and research. Main scientific goals entail the study of MS epidemiology in Switzerland, health care access and provision, as well as life circumstances and wellbeing of persons with MS. The innovative study design ("layer model") offers several participation options with different time commitments. Data collection is by means of regular surveys and medical record abstraction. Survey participation is offered in different modes (web, paper & pencil) and in the three main national languages (German, French, Italian). Participants also receive regular data feedbacks for personal use and self-monitoring, contextualized in the whole population of study participants. Data feedbacks are also used to solicit data corrections of key variables from participants. DISCUSSION: The SMSR combines the advantages of traditional and novel research methods in medical research and has recruited over 1600 PwMS in its first year. The future-oriented design and technology will enable a response not only to future technological innovations and research trends, but also to challenges in health care provision for MS.

trial registrationClinicalTrials.gov   NCT02980640 ; December 6, 2016; retrospectively registered.

Indexed as

Patient-Centered CarePatient ParticipationRegistriesAdolescentAdultBiomedical ResearchClinical ProtocolsHumansMultiple SclerosisProspective StudiesResearch DesignSurveys and QuestionnairesSwitzerlandYoung AdultEpidemiologyHealth-related quality of lifeMultiple sclerosisPatient-reported outcomesSwitzerland

Identifiers

PMID30103695
PMCPMC6088400
OpenAlexW2886422791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.